Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MG-K10 in Chronic Rhinosinusitis With Nasal Polyps
NCT07903194Phase 3Not yet recruiting
- Sponsor
- Hunan Mabgeek Biotechnology
- Start
- Oct 2026
- Primary completion
- Dec 2027
01
Overview
Phase 3, randomised, double-blind trial in chronic rhinosinusitis with nasal polyps (CRSwNP) comparing MG-K10 with Placebo (2 arms). Primary endpoints: Nasal Polyp Score at 24 weeks and Nasal Congestion Score at 24 weeks. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
comekibart
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on NCT07903194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07903194.